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While the skin of most patients with atopic dermati-
tis (AD) is known to contain IgE-bearing cells, the 
contribution of the various IgE-binding structures to 
this phenomenon is not fully understood. To address 
this issue, we eluted cell-bound IgE from cryostat 
sections of lesional AD skin by acid treatment and 
performed reconstitution experiments with IgE in the 
absence or presence of reagents directed against the 
currently known IgE-binding structures. We found 
that incubation of acid-treated sections, with either 
chiIneric or serum IgE, resulted in the appearance of 
sizable numbers of anti-lgE-reactive cells. This cel-
lular IgE loading could be entirely prevented by 
preincubation of the sections with the anti-FceRIa 
MoAb 15-1 but not with either antibodies against 
FceRII/CD23 and FcyRIIICD32 or with a-lactose. To 
exclude the possibility that acid treatment of tissue 
sections may have adversely influenced the IgE-bind-
ing capacity of IgE receptors other than FceRI, we 
A !though the cen tral role of allergen-specific IgE in the pathogenesis of respiratory allergy is w e ll estab-lished , its contributio n to th e eczematous lesions in cutan eous atopy is sti ll a m atte r of conjecture and deb ate. Eviden ce supporting this involvement com es 
from the findings (i) that dend,;tic antigen-presenting cells (APes) 
in lesion a l and , to a lesser extent, in n o nlesional skin of atopic 
de mlatitis (AD) patients fi·equently exhibit surface-bound IgE 
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performed an identical series of experiments on AD 
skin samples that, as an exception, were essentially 
devoid of anti-lgE-reactive cells. Again, no IgE load-
ing was detected when these sections were preincu-
bated with anti-FceRIa MoAbs. In contrast, preincu-
bation of the sections with a-lactose and/or MoAbs 
against FceRIIICD23 or FcyRIIICD32 did not affect 
IgE loading. Together with the observations that 
anti-FceRIa-reactive and IgE-binding cells are 
largely overlapping populations and include cells of 
the Langerhans ceWdendritic cell lineage, mast cells, 
and a few dermal dendrocytes and eosinophils, our 
results demonstrate that FceRI is the predominant 
and, perhaps, the only biologically relevant IgE-
binding structure on histogenetically and function-
ally diverse cell populations of AD skin. Key Ivords: 
Iligil-affillitJl receptor fOY IgEllgE+ alltigell-presentitlg cells. 
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molecules (Bruynzee l-Koomen e( ai, 1986; B arker e/ ai, 1988; 
Bieber e/ nl, 1989a), (ii) that Langerhans cell (LC )-induced allergell-
specific T cell activati.on and prolife ratio n occur more e ffectively 
when the alle rgen is taken up via these celJ sUl'face-bound IgE 
molecules (MlIdde et ai , 1990), and (iii) that eczematous reactions 
to aeroaBergens can be most efficientl y induced via skin regio ns 
h arboring IgE-bearing dendritic cells (DCs) (Mudde et ai, 1990) . By 
reasoning that the prevention of IgE-faciUtated allergen presenta-
tio n co uld be an e ffective m eans to stop the cascade of pathogenetic 
events occurring in AD, we and others aimed to charac te rize the 
IgE-binding structure(s) on APCs in AD skin. Candidate molecules 
include (i) the low-affinity recep tor for IgE (FcERlIlCD23), a 
single- chain type-II integral m embrane molecule (Sutton and 
Gould , 1993) wh ose expressio n and release can be induced by 
interle ukin 4/interferon-), o n various cell types including LCs 
(Bie be r et ai, 1989b); (ii) galectin-3, a /3-galactoside-binding protein 
(B arondes e/ ai, 1994) pro duced by a variety of cells including 
ke ratinocytes (KCs) (Wollenbe rg el ai, 1993) , and monocytesl 
macro phages (Lill el ai, 1995) ; and (iii) the high-affinity recep tor for 
IgE (FcEIU) expressed as a tetrameric holoreceptor on mast cells 
and basophils (Ravetch and Kiner, 1991; Sutto n and Gou ld, 1993). 
Eviden ce for the participation of FCERIlICD23 in IgE binding to 
LCs in AD skin cam e fi·om the fi ndings (i) that the monoclonal 
antibody (MoAb) BBI0, supposedly directed aga inst FCERlIlCD23 
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(Capron ef nl, 1986), prevents the binding of IgE immune com-
plexes to LCs (Bruynzeel-Koomen et ai, 1988) and (ii) that 
epidermal DCs isol ated 5'om lesional AD skin react w ith anti-CD23 
MoAbs (Woll enberg ci nl, 1996) . An involvement of KC-derived 
galectin-3 is also conceivable, because this molecule binds to LCs 
and modulates their binding capacity for specifi c IgE glycofonns 
(Wo llenberg el nl , 1993). A role for the high-affinity IgE receptor 
can be derived from the findings that epidermal (Dieber e( nl, 1992; 
Wang el nl, 1992) and dermal (Osterholf el nl, 1994) DCs of normal 
human skin as well as LCs from atopic individuals (Dieber and 
Ring, 1992; Grabbe e/ nl, 1993; Jurgens el nl , 1995; Wollenberg e/ 
nl, 1996) react with anti-FcelUa MoAbs and bind monomeric IgE 
via this receptor (Dieber and R.ing, 1992; Wang CI nl, 1992; Jurgens 
el nl , 1995). 
This study was un dertaken to assess the re lative contribution of 
FcelUI, ga lectin-3, and FCEIU for the binding of monoelonaJ and 
serum IgE to resident and passenger leukocytes in AD skin. 
MATElUALS AND METHODS 
Patients and Sample Collection Skin specimens from 26 adu lt AD 
patients, diagnoscd accordin g to the criteria of Hanifin and R.njka (1980) , 
wcre studicd . T he paticnts receivcd nc ithcr ora l medication nor topica l 
corticosteroids for at least 2 wk prior to skin sampling. After informed 
consent \vas obtained, 4-111111 punch biopsies were taken from les io na l skin 
under loca l anesthesia. Control specime ns consisted of normal skin from 11 
health), non-atopic donors and of tonsil s removcd fi'om a patient with 
chronic tonsilli tis. Serum of AD paticnts and health)' control individuals was 
o btaincd from venous b lood s'lI1lples and kept fi'ozen at - BO°C. Serum IgE 
concentrations wcre determ ined b), using the capacit)' (CA P) IgE flu o-
rescin e imm unoassay (FEIA) (Pharmacia-LlUJ. Uppsala , Sweden). 
Preparation of Tissu c Spccimcns Biopsies were embedded in Tissue-
Tek II OCT (Mi les Laboratory, Elkha rt, IN) , frozen in 2-mcth), lbu ta ne 
(Merck, Darmstadt, Germ an),), cooled w ith liquid ni trogen, and sto rcd at 
- 80°C until further usc. Cr),ostat sections (5 J1.111) were Cllt. mounted o n 
pol)'-(L-Iys ine) (Sigma, St. Lou is, MO)-coated slides, air-dried. and fixed in 
acetone (4°C) for 10 min . 
Cell Lincs Human Epstein-Barr Virus (EBV)-transforl11cd B cell s were 
washed in RPM I medium 1640 (GIBCO BRL. Grand Island . NY). 
sedimented o nto Adhesion Slides (Bio-Rad. Richmond. CAl, and fixed in 
acetone (4°C. 10 min) . 
Antibodies and Reagcnts T he fo llowing MoAbs we re used as blocking 
reagents: mouse anti-FcEfUCt (15-1: 10 J1.g per ml; Wang el ai , 1992), 
anti - FCEIUI /CD23 (MHM6; 9-44 J1.g per ml: DAKO A/S, Glostrup . 
Denmark), and anti-FcyR.lI /CD32 (IV.3; 10-40 J1.g pcr ml; Medarcx, 
Carlsbad, CAl. a-Lactose was from Sigma-A ldrich C hemic, Deisenhofcn, 
Gcrmany. Primar), antibodies used for immunostaining included MoAb 
1.5-1 (anti- FcElUCt; '1.4 J1.g pe r ml), MoAb MI-IM 6 (anti-Fc€R II /C D23: 4.4 
J1.g per ml), non labcled or biotin),lated (B lOT) mouse anti-human IgE 
MoAb (2-5 J1.g per 1111: Southern Biotechno log), Associates, Birmingham. 
AL), pol)'c1ona l rabbit anti-human IgE (1 :500 dilution; CLB. Amsterdam. 
The Netherlands), mouse MoAb to human dendriti c ce ll s (RFD I ; 10 J1.g pe r 
mJ; Serotec, Oxford, U.K.), B IOT-mollSe MoAb anti-human mast cell 
c h)'mase (2 J1.g per ml: C hemicon International, Tcmecula. CAl, m OllSe 
MoAb anti-eosi nophi l ca tiOltic protein (EG1: 1 J1.g per 1111 ; Sera- Lab. Sussex. 
UK). and rabbit po lydona l anti-coagulation facto r X lll a antibody (1 :800 
dil u tion; Behring, Marburg/Lallll . Ge rman)'). Fluoresce in isothioc)',mate 
(F1TC)-labeled m o use MoAbs included anti-CD45 (l-ILe-1-FITC: 2 J1.g pcr 
ml; Becton Dickinson. Mountain View, CAl, anti- HLA-DR (1 .2 J1.g per ml; 
Becton Dickinson), anti-CDla (OKT6-FITC: 2.5 J1.g per ml: Ortho Diag-
nostic Systems, l"ta ritan , NJ), anti-CD3 (UCHT1-FITC: '1 J1.g per ml; 
DAKO A/S) . and anti-CD19 (Leu 12-FITC; 2.5 J1.g per ml: Becton 
Dickinson) . 
IgE-Binding Assay After elutio n of tissue-bound IgE with gl),cine 
h),drochloride bu ffer (0.05 M gl),cine. 0 .085 M NaCI , 0.005 M KC I. 0.01 M 
ethylenediaminc tetraacetic acid, pH 2.5: Ishizaka and Ishi zaka, 1974) for 30 
rnin 011 ice, cryostat skill sectio n s wcre incubated e ither overni ght at 4°C 
w ith 111 0noclonni chinl cri c (hU111an COll stant regio n heavy chain Ehn o usc 
variab le region heavy chain / light chain) IgE anti-NP (dgE: 2.1- 3.6 J1.g per 
1111; Scrotec) o r for 1 h at 37°C with undiluted sera fi'om AD patients with 
IgE concentrations from 2. 1 to 3.6 J1.g pCI' ml. In cerwin experiments, 
cryostat sections were pre-exposed overnigh t :It 4°C to reagents known to 
inhibi t IgE binding to the various IgE reccptors (sec "Antibodies and 
Reagcnts") prior to their incubation with c1gE o r hum'1I1 sera . IgE binding 
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was visualized as described be low (sec " Immunostaining"). Monoclonal 
ch.imeric IgG2 anti-NP (2.1-3.6 J1.g pCI' ml; Serotec) or undiluted serum 
from non-atopic hea lthy individuals was used as negative control. 
Itnmunostainillg Slides wcre washed in Tris(hydro"'y m cth),l)amino-
methan e-buffered sa line (PH 7.6) between incubations . To prevent non-
specifi c prote in binding, sections werc "blocked" with 5% sheep serum/3% 
hlllll an AB serunl (Scrotcc/JI11tllUnO AG , Vienna , Austria) for] h at rOO I11 
temperature prior to incubation with the p';mar)' antibody. Antibodies and 
se ra were d ilu ted with staining buf\-cr containing 5% (wt/vol) milk proteins 
an d 0.1 % polyoxyethylene sorbitan monolaureate (Tween 20: Bio-Rad). 
Immul1opcroxidasc Single Staining For the detection of IgE, tissue 
sections or EBV-tral1Sformed B cells immobilized on Adhesion Slidcs were 
incubated with BlOT mouse anti-human IgE MoAb fo llowcd b)' peroxi-
dase-conjug:lted streptavidin complcxcs (StreptABComplex/ HRP; DAKO 
A/S) and 3-amino~9-eth)' 1 carbazole (Sigma-Aldrich C hemie) in acetate 
buffer (pH 5.0). For the demonstration of tissue-/cell -expressed FaR] or 
FceIUIICD23 . the incubatio n chain consisted of mouse MoAb 15-1 or 
Ml-IM6, of BlOT -F(ab '), shcep anti-mo use immunoglobuli n (1 :800 dilu-
tion : Amersham, Littlc Chalfont. UK), and finall )" of thc StreptABCom-
picx / HIlP staining kit. Sections were countcrstaincd \vith hClllatoxilin 
(Merck) and mounted in phosphate-buffered sa line/glycerollMowiol 
(I-Iocchst, Frankfurt am Main , Germany). 
Double Immunofluoresccncc Staining Cryostat sections were incu-
bated overn ight at 4°C with one of the primar), MoAbs (anti-human IgE. 
15-1, MHM6. or EG l) , followed b)' tetramethylrhodamine isothioc),anate 
(TlUTC)-labclcd affinity-purified goat anti-mouse IgG (l0 J1.g per ml: 
Atlantic Antibodies. Stillwater, MN) for 1 h at room temperature. To 
increase the detectability of tissue-bound primar), antibodies. sections were 
exposl!d to mouse IgG l (J J1.g per ml: 4S min , room te!11perature: 
Sigma-Ald,-ich C hemic) fo llowed b)' a second exposure to T RITC-conj u-
gated goat anti-mouse IgG (10 J1.g per ml). Sections were then stained 
overnight at 4°C with either (i) one of the F1TC-labeled MoAbs (sec 
"AJl tibodies and "-eagcnts"). (ii) rabbit anri-FX lll a antibod ies followcd b)' 
FITC-conjugared affinity-purified swine anti-rabbit immunoglobulin (1: 1 00 
dilution: DAKO A/S), (iii) MoAb I"tFD I followed by F1TC-labcled rat 
an ti-mouse IgM (10 J1.g pe r m l; Southern Biotechnology Associates) "nd 
therea ftc r b)' F1TC-labeled F(ab ' )2 goat anti-rat immunoglobu Lin (S J1.g per 
1111; Jackson Im!11unoResearch Laboratories. West Grove, PAl, (iv) BlOT 
mouse anti-ch),mase MoAbs fo llowed by FITC-streptavidin (1: 1 00 dilu tion; 
Amcrsham). o r (v) rabbit anti-human IgE antibodies followed by FITC-
labeled swine anti-rabbit immunoglobuLin (1:100 dilution; DAKO A/S). 
When directl), conj ugated mOll se IgG MoAbs were used for counterstain-
ing, the sectio ns were saturated w ith non labcled mousc IgG1 (1-2.5 J1.g per 
m l) or mouse IgG2a MoAbs (1.2 J1.g per ml ; both from Sigma-Aldricll 
C hemic) of irrelevant spec ifi city. Appropriate (non)labe led isotype-
matched antibodies were used as negative controls. All slides we re finall ), 
embedded in phosphate-buffered sa line/gl)'cero l/ Mowiol. 
Quantification and Lin eagc Markcr Analysis of IgE+ and FCERIa+ 
Cells in Epidcrmis and Dcrmis Peroxidase- labe led IgE+ cells, present 
in fivc to ten arbitraril ), chosen fie lds (covering an area of = 0.5 111m') of the 
cp idcrl11is as we ll as 111id and u pper dcrnl is. were counted "vith a scrni-
autol1latic image ana lyzing s),ste l1l (Vidas, Kontron Elektronik. Eching. 
German y) ,md d,na were expressed as cells per 111m2 (mean :t SD) . Rcsu lts 
obta,ined for various experimcntal groups were compared using the Tukey-
Kramer Multiple Compariso ns Test and p values of < 0.05 were considered 
to be statisticall ), signifi cant. For immunofl uorescence (F IT C vers us 
TRITC) double-labeling studies, to determine the proportion of IgE; or 
Fc€IUa + ce ll s express ing a b';ven lil1ctlge marker. we screencd fivc to seven 
sequentia l fields of the epidermis or mid / upper dermis by using an 
cpifluorescence microscope (Nikol1. Tokyo, Japan) tit a X400 magnifica-
Table I. Lesional AD Skin (AD) but not Skin from 
Non-Atopic Health y Volunteers (HV) Harbors Numerous 
IgE-Bearing Cells" 
HV AD 
(11 = 9) (n = 9) 
Epidermis 0 120 ± 64 
Dennis 11 ± 9 437 ± 93 
,I IgE f- cells were visualized by irnmllll 0pcrox-idasc staini1lg. Five co 10 arbitrarily 
chosen microscopic fields (covering: an arca of ""'0.5 111111 2) of rhe epidermis as well as 
mid and upper dennis were cOlllHcd w ith a se l11i-~HIl"Oll1nti (" image analyzing system . 
Data arc expressed as numbers per mm1 (Illl!an ~ SO). 
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F i ure 1. IgE expression b y A D skin cells r e sults from serum IgE binding via F CER!. Serial cryosta t sectio ns o f Ie sio na I AD skin we re stained with 
an ti- lgE in an indirect iml11unopcroxidase procedure afte r bav ing been subjec ted to Tris(bydroxymethyl)amino l1le thanc-buffercd sa linc (a). ac id trcatmeIlt 
(b), acid treatm ent fo llowed by slgE (() , acid treatment consecutively fo llowed by anti-FcERJ a MoA b and slgE (d), and acid treatm ent fo llowed by a mix ture 
o f reagents known to block 19E-binding to FCEIUI /CD23, FCl'RJI /CD32, and gai<:ctin -3 and then by 51gE ( .. ). Dl ack dots del in ea te the dermal- epidermal 
j unctio n. Scnlc· hnr, 30 !L1ll . 
tio n. T be to tal nu m ber of cells labeled wi th each antibody and of cells that 
wcre do uble-stained was counted and the pe rcentages of the cell s ex press-
ing both an tigens was ca lcul ated . 
RESULTS 
AD L esions but Not Skin of Nonatopic Persons Harbo r 
Large Numbers of IgE-Bearing D e ndritic C e lls III acco r-
dance w ith previo us reports (Bruynzeel-Koom en c/ Ill , 1986; Leun g 
cl Il l , 1987; Barker ct Ill , 1988; Bieber ct ai, 1989<1) , anti-l gE 
immuno5taining of les io nal AD skin stain ed numero us cell s within 
both the dermis and the epidermis (Table I) . IgE -I- ce ll s in th e 
upper ski n la ye rs were largely dendriti c, freque ntly associated w ith 
the microvascul ature, and tended to fo rm clusters (Fig 1a) . In sharp 
contrast, norm al-appeat'in g skin o f health y volun teers con tain ed 
o nl y few IgE 1- cells (Table I) loca lized in th e uppt! r and mid de rmi s 
(data no t shown) . Immuno Auorescence do uble labe ling of AD 
sectio ns revea led that virtu ally all IgE+ cells in the epide rmi s and 
the m aj ority of IgE+ cell s in th e dermis exhibi t anti-CD1 a and /or 
RFD l reacti vity (Ta ble II, Experilll ellt 11) indi ca ting th at these cell s 
belong to the LC/ DC fa mily. O th er ' gE ~' cells of the dermis 
included chym ase- containin g m ast ce ll s, EG I + eosinophils, and 
FXliia + dermal dendrocyws (Table II , Experilll cllf 11). T he lym-
phocyte po pulatio n o f AD skin , which consis ts alm ost exclusively 
ofT lymph ocytes, fa iled to ex press IgE (data no t shown). 
Masking the IgE-Binding Site of F cERI 0', but Not the 
Functional Blockade of Other IgE Receptors, Prevents 
Binding of Chimeric and Serum IgE to AD Skin Sections 
III a first se ri es o f experimen ts, we eluted ill lI it/o-bo und IgE by 
washing les ional AD c;·yosta t skin sectio ns wi th acid-g lyc ine buffer 
(Fig 1b) and dem onstrated that in cubatio n of these "stripped" 
sectio ns with either c1 gE or atopi c st! rum con ta inin g a high titer of 
IgE (slgE; 3.6 fLg per ml) rt!sults in an an ti-l gE stainin g pattern that 
is qu alitati ve ly and quantita ti ve ly indistinguishable fi 'om that of 
un treated skin (Figs 1 , compare a w ith c; 2a,b) . O ur furth er 
o bservatio n that . th e propo rtio nal expression o f vari o us lineage 
m arke rs (CD l a, M.oA b RfD I-reacti ve mo ieties, chYll1ast!, eosino-
phiJ cati onic pro tein , FX '"a) by IgE-bearin g cell s ill "i llo (Table II , 
T abl e II. h n munophcnotypic Profiles of AD Skin Cells Binding IgE 
Epidermjs (n = 7) 
Derm is (n = 7) 
Epide rmis (n = 7) 
Dermis (n = 7) 
C D!a 
77 ± 12 
27 ± 9 
CDl a 
85 2: 14 
21 2: 1 0 
(n) Percent of ill "iPel IgE cell s exp ress ing;] given 111:lrkc r 
R FDI C hYl11a sc EG I 
91 2: 6 0 0 
80 ± 12 7 ± 3 3 ± 2 
(b) Per em of clgE-binding cell s expressing a given marke r 
I~FD I C hymase EG I 
93 ± 5 0 0 
73 2: 9 8 2: 3 2 2: 
FX III " HLA- DR CD45 
0 93 2: 8 98 2: 2 
4 ± 3 79 ± II 92 2: 5 
FXllla HLA-D R C D45 
0 94 ± 4 89 2: 7 
3 ± 1 82 ± 15 93 ± 5 
I I T he proportio n oflgE"1 cells expressillg a given lin eage Il wrkcr was determin ed hy iml11un ofl uorescence doubl e-labding studi es. Five to seven sequen tia l ~ic lds o f the epidermis 
,wd mid/ upper den n is were scree ned by lIsin g an cpiHu orcscencc mi croscopc. R.esul ts arc: cxpressed as pcrcc lll'agcs uf IgE+ ce lls (mc~1I1 .:!: SO) hea ring a givell marke r. 
It AD cryost;It skin sections were sllbjectcd to aci d u'catm cnt fo ll owcd by incuba tion with cJgE. T he pro portio n o f clgE i l:c ll s ex pressing a given lill e a~c markcr W ,l S dcte rm ined 
as descri bed ;Jbovc. R..csul ts arc expressed as pen:cnta gcs o f cl gE + cc ll s (m cn ll :!: SD) bcarin g a given marker. 
., , 








































50 100 150 200 250 300 350 400 450 500 550 
number of clgE+ cells/mm2 
ID epidermis I ~ dermis I 
J$#j------1 
lmmUmnf Mift::j 4-----1 
bmmm _ lmtW4~ 
50 100 150 200 250 300 350 400 450 500 550 
number of slgE+ cells/mm2 
Figure 2. MoAb 15-1 blocks dIe binding of monoclona l chimeric 
(a) and serum (b) IgE to acid-treated cryostat sections of A D skin. 
Serial CJ'yostat sections from ninc AD biopsies we re stained with anti-l gE in 
an indirect il11lllunoperoxidase label ing procedure afccr having been sub-
jected to the experilllenta l procedure descri bed ill the fig ure . Data were 
co llected and expressed as o utlined in Mara;n/s nm/ iV/el/II"/s. (n) Anti- Fc€Rl a 
MoAb 15-1 . (b) Anti-Fc€RJI /CD23 MoAb MHM6. (c) a -Lactose el uting 
galectin-3. (d) Ant.i-Fc€IU I/CD23 MHM6 and anti-FcyRJ I/ CD32 IV.3 
MoAbs. ' Statisticall y significan t (p « l.05) differences between experimen-
ta l groups 4, 5, and 6 and the positive contro l e"peril1l ental gro up 3. Err"r 
bars, SJ). 
Experil/l ellt a) corresponds to that of IgE-binding cells ex lJi"O 
(Table II, Experil/lellt b) strongly suggests tha t the above experi-
mental system is su ita ble for the characte rization of biologicall y 
releva nt IgE-binding structures ill IIilJo. 
We therefore exposed "stripped" AD skin sections to reagen ts 
known to interfere w ith IgE binding to FceRJ , FceRJ IICD23, 
ga lectin-3, and / or FcylU IICD32 (see /\Ilateria ls afl(l Methods) and 
then subjected these specimens to the IgE/anti-l gE incubation 
protocol. Results obtai ned showed that the anti-FcelUa MoAb 
15-1 (10 /-Lg pCI' 1111) completely blocked binding of clgE (Fig 2a) 
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or slgE (Figs ld; 2b) to the cells of epidermis and dennis. In sharp 
contrast, the anti-Fce1UIICD23 MoAb MHM6 (9 - 44 /-Lg per ml) , 
a-lactose (O .2-0.5M) , or the anti-FC')'LUI/CD32 MoAb IV.3 
(10-40 /-Lg per ml) neith er visibly uor numerically inhibited cJgE 
and sl gE binding (Fig le, 2a,b). The validity of these IgE-binding 
inh.ibi tion studies is furthe r substantiated by our finding that MoAb 
MHM6, but noc 15-1 , blocked IgE bindi,ng to FcElUI/CD23 ~ 
human EBV- transformed B cells (Fig 3) and tonsillar B lympho-
cytes (data not shown). 
To test the possibility that acid treatmen t may have altered the 
IgE-bincling capacity of receptors other than FceRJ, we carried out 
an identical series of inhibi tion experimen ts on .lesional AD skin 
sections that, as an exception, displayed no detectable ill " illO bound 
IgE and th us allo.wed us to omit the acid treatment step. As w ith the 
situation w ith AD skin sections expressing ill ,Ji"o bound IgE, the 
al1 ti-Fc€RJa MoAb, but none of the other reagents (MHM6, 
a -lactose, IV.3), prevented the binding of cJgE (Fig 4a) and sIgE 
(Fig 411) to these specimens. 
An additiona l aJ'gument for che critical importance of FceRJ for 
IgE binding to AD skin cells ca me from the anti-FceLUa single-
colo r immuno.labeling studies on "stripped" AD skin sections, 
which revea led a pattern (Fig 5) closely resembling that of anti -IgE 
staining of native AD skin sections (Fig la). This analogy wa s 
furthered by immunofluorescence double-l abel ing experiments 
showing that the vast majority of FceH.Ja+ cells in AD skin are 
LCs/ DCs (Fig 6), The few remainin g FcelUa+ cells included 
virtuaLly the entire population of chym ase-con ta ining m ast cells, 
50-60'1., of EGl '" eosinophils, and = 5";', of FXlIl a+ derm al den-
drocytes (data not shown). 
DISCUSS ION 
In the skin of AD patients, LCs, dermal dendritic cells, mast cell s. 
and eosin oph ils frequently bear cell surface-bo und IgE molecules 
(Bruynzeel-Koom en ct ai, 1986; Leung ('/ ai, 1987; Barker et ai, 
1988; Bieber CI ai, 1989a, Tanaka ('{ ai, 1995; th is study). Although 
these cells apparently express various types ofIgE-binding moieties, 
i.e. , FcelU (Bieber ct ai, 1992; Wang et ai, 1992; Gounni ct ai, 1994; 
Osterhoff et ai , 1994) , FceRII / CD23 (Capron ei 111, 1986; Bruyn-
zeel-Koom en et ai, 1988; Bieber et ai, 1989b; Sakamoto ct ai, 1990 ; 
Buckley ef ai, 1992) , and ga lectin-3/EBP (Truong et ai, 1993; 
Wollenberg et ai, 1993; Liu et ai, 1995), the contribution of the 
individual IgE receptors to the iI, IIilJO binding of serum IgE by AD 
skin cells has not been fu lly clarified . H erein. we provide evidence 
that, despite the reported presence of different IgE receptors in AD 
skin, FcelU is selectively responsible for cellular IgE binding. This 
is substantiated by the fi ndin gs thilt an anti-FceIl.Ja MoAb pre-
vented the binding of m onoclonal (Bieber and Ring, 1992; W ang 
1'1 ai , 1992; this study) and polyclonal (tlus study) serum IgE to 
eith er acid-treated AD skin sections (i.e., cryostat sections fr0111 
which ill ";110 bound IgE was elu ted) or sections devoid of detect-
able ill IIi/ /O bound IgE. In contrast, reagents known to prevent IgE 
binding to FceRII /CD23 (Aubry Cl ai, 1986) and galecti n-3 (Frigeri 
and Liu , 1992), as well as an tibodies against FcyIUIICD32, an 
Figure 3. MoAb MHM6 (a) , but Not 15-1 (b), blocks IgE-binding to Fc€RIIICD23-expressing EBV-tran sformed B cells. EBV-transformed B 
cells sedilllcnted on Adhes io n Slidcs were sta ined with anri- lgE in an indirect illll11unoperoxidasc labcl.i ng procedure after ha vi ng becn subjected to c1gE (a) . 
anti-Fc€RII /C D23 MoA b MHM6 fo llowed by c.IgE {II). or "nti-FccIU a M oA b 15-'1 and c1gE (e). Scale bar. 30 J.lIll . 
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Figure 4. MoAb 15-1 blocks the binding of monoclonal chimeric 
(a) and serum (I,) IgE to nOIl-acid-treated cryostat sections of AD 
skin devoid of detectable ill ''; 110 bound IgE. Seria l cryostat sections 
from fo ur AD biops ies were stained with anti-l gE in an indirect immuno-
peroxidase labe ling procedure after havi ng been subjected to the experi-
menta l procedure described in the figure . Data we re collected and ex-
pressed as o utlined in Materials alld Met/llld ... (a) Anti-FcEIUu MoAb] 5-·1. 
(b) Anti-FcEIUIICD23 MoAb MHM6. (r) a-Lactose elu ting ga lectin-3. (d) 
Anti-FcElUIICD23 MHM6 and anti-Fc-yIUIICD32 IV.3 MoAbs. ' Statisti-
ca ll y signifi cant (p < 0.05) differences between experimenta l groups 3, 4, 
and 5 and the positi ve control experimental grou p 2. Error bars, SD. 
IgE-bindin g structure in rodents (Takizawa et (/ /, 1992), fai led to 
interfere with the binding of e ither of the two IgE preparations (this 
stud y) . A furthe r argument for the criti ca l a.nd l1I1.ique ro le of FcElU 
in IgE bindin g to AD skin cell s comes fi·om o ur findin g tha t the 
anti-FcElUa-reactive cells in AD epidermi s and dermis disp lay a 
simil ar, if Dot identical, ce ll morph o logy, t issue distri bution , and 
immunophenotype as the cells bearin g IgE ill /J i /Jo and binding IgE 
ex /J i /Jo. 
Our fil ilure to block IgE binding to AD skin cell s with the 
anti-C.023 MoAb MHM6 may be su rprisin g in view of reports 
descl·ibing (i) FcEfUIICD23 expression on various types of AD skin 
ce lls (B ru ynzeel-Koomen et (/ /, 1988; Sakamoto ct (//, 1990; Buckley 
et (/ /, 1992; WolJenberg et (/ /, 1996) , (ii) cytokine (in terl eukin 4, 
interferon y) -induced lip-regulation of FCERU/CD23 o n LCs 
(Bieber el (/ /, 1989b), and (iu) inhibi tio n oOgE-bindin g to APC by 
the "anti-CD23-like" MoAb BB10 (Bruynzeel-Koomen ef (//, 
1988). We have also obtain ed ev idcnce that, in both IgE+ and IgE-
lesio n:!1 AD skill samples, the anti-CD23 M oAb MHM6 stain s a few 
cells in the epidermis and dermis (R. Klubal, unpublished o bser-
vation) . O ur fin din g that ac id treatment compl etely rem oves the 
anti-CD23 reactivity of AD skin sections (with o r without IgE+ 
cell s) but not that of tonsillar sections o r EBY - transform ed B cells, 
suggests that FCEIUI/CD23 in AD skin is present ill its soluble 
rather than in the acid-resistan t transmembrane form. Nevertheless, 
the possibility exists that, becausc of limita tio ns in the sensitivi ty of 
immuno histochemica l m ethods , m in llte quanti ties o f transme m-
brane C023 m ay have esca ped o ur detection . Bven if this were tbe 




Figure 5. Anti-FceRIa labeling of an acid- treated cryostat section 
of AD skin results in a staining pattern simi.lar to that observed 
with anti-IgE in a serial section (sec F ig ure 1a) . A section fi·om the 
tissuc b lock used for thc imll1l1l1oscnin ing dep icted in F ig 1 was subjected to 
acid treatment and srained with anti-FcER.l a MoAb 15-1 ill an indirect 
ill1lllunoperoxidasc procedure. l3Iack dots delineate the derlllal- epidcnnaI 
junction. Scale bar, 30 /-L1I1. 
case, o ur blockiJl g and reconstitu tion studi es on acid- trea ted and 
untreated sectio ns show tha t FcelU I/C023 docs not significantly 
con trib ute to c1gE or sIgE binding to les ional AD sk in cclls. 
T he {3-ga lactos ide-binding lectin , ga lectin-3, is expressed by KCs 
(Wo llenberg el ai , 1993) and mo no nuclear phagocytcs (Liu cl (//, 
1. 995) and ca n bind various o ligosaccharid e-rich stru ctures, includ-
ing IgE and IgE receptors (Darondcs cl tI/, 1994). R .. ecently, 
Wollenberg el (/ / (1993) reported that the presence of KC-derived 
ga lectin-3 a Ll ows the binding of (poorl y sial ylated) hum an IgE to 
LC ill lI i lro. O ur results argue agai nst a critical ro le of ga lectin-3 in 
the b inding of monoclonal o r serum 19B to AD skin ce LI s, because 
3nti-FcEIUa MoAb treatment completely prevented and a -lactose 
neithcr positively uo r ncgativel y influe nced cell ular IgE loadin g. 
Data prescnted in this stud y further demon strate that thc vast 
nH~ori ty (> 80%) of AD skin cells c<lpabl e of FCElU-depcndent IgE 
binding belo ng to the lineage of COl a ' and I o r RFDl + dendritic 
ce lls, w hereas mast ce ll s, FXllla-cxpressin g dermal dendrocytes, 
and EG1 + eosi nophils together accoun t for only 15%, of IgB-
binding ce lls ill the dermis. Conccrnin g thesc latte r cell popu la-
tions, o ur immunoflu orescence double-sta ining protocol allowed 
for a direct dem onstration of FCERIa on mast cell s and certain 
FXIIla + dermal dendrocytes but not o n eosinophils. N evertheless. 
o ur recent o bservation that anti-FcEla M oAb 15-1 treatm ent of 
ac id-treated AD skin sections preven ted 19B binding to EGl + 
dermal ceUs (R.. Kluba l, unpubl ished observation) as well as 
immuno hi stologic studies by GOllnni el (/ / ( 1994) and Ta naka el (// 
(1995) led us believe that FCEIU is the critica l IgE-binding structure 
also on eosino phils. 
A lthou gh definitive proof is lackin g, it can be assumed that 
FCEIU , as in its role 011 peri pheral blood APCs (Maurer cl (/ / , 1995; 
VO L. 108. NO.3 M AR C I-I 1997 Fc<I,"I-T H E C IUT ICAL IgE-OI ND ING STR UCTURE IN AD SKIN 341 
Figure 6. Anti-CDla- and anti-Fc€Rla-reactive cells of an acid-treated cryostat section of AD skin comprise largely overlapping cell 
populations_ An acid-treated cryosta t sectio n o f AD skin was reacted with the anti-FceRJ ey Mo Ab 15-1 (T RITC ) and with MoAb anti-CDl a (FITC) as 
o u tlined in M fl lerinls fllld Melh ods. Photomicrographs resulted fi'om either single (TRJTC (a) or FIT C (I))) or double [TRJTC and FITC (r) ) exposure. White 
do ts delineate the dermal- epidermal junctio n. Scale bar, 30 fLm . 
M aurer e/ ai , 1996), serves as an IgE-dependen t allergen-focusing 
receptor on LCs/D C s. I f so , FceRl-bearing LCs may playa criti cal 
ro le in the pathogenesis of AD, because these cell s are the first 
professional APCs to intera ct with exogeno usly delivered allergens 
and/or IgE-reacti ve epiderma l cell -derived autoantigens (Valenta eL 
01, 1996). It is al so feasible that allergen- induced activation o f 
FceRl signaling pathways results in the production and release o f 
m ediators by LCs th at may disturb th e epidermal barri er and/or 
trigger the emigration of allergen-modified LCs into the dermis . 
T his m ay allow cell-bound and/or soluble allergens to enter the 
derma l compartment. The latter event may f., vor the degranulatio n 
of m ast cells, whi ch, by the re lease of endothelial cell ac tivating and 
ch emo tacti c £actors, m ay initiate the influ x o f a varie ty o f blood-
deri ved cells includi.ng a Ll ergen-specifi c (type 2) T cells (van del' 
H eijden el ai, 1991 ; Mi.iller el ai, 1993) , as w ell as FceRl-expressing 
eosinophil s and APCs (S . Wichlas, unpublished observations) . 
Paralleling these events, LCs/D Cs may process the allergcns taken 
up via FceRl and present thc all ergen-del;vcd peptidcs to T 
lymphocytes in th e ski.n and/or draining lymph nodes. C ontinuo us 
supply of IgE-reactive exogenous and/ or endogeno us allergen to 
FceRl + resident and newly attracted APCs will , th erefore, lead to 
a prolo nged infl ammatory tissuc reaction composed o f a T cell-
dep endent as well as a T ce ll-independent component. 
Followin g thi s reasonin g, interference with the IgE-binding 
abili ty and/ or fun ctio nali ty of FceRl should be a promi sing strategy 
for early and e fTi cient interruption o f the pathogenetic circuits 
o perative in ato pic ti ssue inflammation . 
/lVe thallk Lallm A. Stillgl jor crilically readillg Ihe IIInllI/SCJ;P f. T his lIlork lIlas 
suppOJ1ed, ill pari, by grallls Fom the A ll.llrin/l deure FO/ /JIdtlf iou (S06702-MED) 
a"d f ro III the l\'olla ,.,.;s Research fll stitlil e. (VieIllUl , A llstriil) . 
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